Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Noncoding regions are the main source of targetable tumor-specific antigens.

Laumont CM, Vincent K, Hesnard L, Audemard É, Bonneil É, Laverdure JP, Gendron P, Courcelles M, Hardy MP, Côté C, Durette C, St-Pierre C, Benhammadi M, Lanoix J, Vobecky S, Haddad E, Lemieux S, Thibault P, Perreault C.

Sci Transl Med. 2018 Dec 5;10(470). pii: eaau5516. doi: 10.1126/scitranslmed.aau5516.

PMID:
30518613
2.

Physiological and Psychological Adaptations of Trained Cyclists to Spring Cycling Camps.

Dionne JF, Lajoie C, Gendron P, Freiberger E, Trudeau F.

J Hum Kinet. 2018 Oct 15;64:137-146. doi: 10.1515/hukin-2017-0188. eCollection 2018 Sep.

3.

HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.

Wang Z, Wang W, Cui YC, Pan Q, Zhu W, Gendron P, Guo F, Cen S, Witcher M, Liang C.

J Virol. 2018 Sep 26;92(20). pii: e01135-18. doi: 10.1128/JVI.01135-18. Print 2018 Oct 15.

PMID:
30068653
5.

Cardiovascular disease risk in female firefighters.

Gendron P, Lajoie C, Laurencelle L, Trudeau F.

Occup Med (Lond). 2018 Aug 11;68(6):412-414. doi: 10.1093/occmed/kqy074.

PMID:
29846677
6.

Cardiovascular health profile among Québec male and female police officers.

Gendron P, Lajoie C, Laurencelle L, Trudeau F.

Arch Environ Occup Health. 2018 May 4:1-10. doi: 10.1080/19338244.2018.1472063. [Epub ahead of print]

PMID:
29727597
7.

Cardiovascular Disease Risk Factors in Québec Male Firefighters.

Gendron P, Lajoie C, Laurencelle L, Trudeau F.

J Occup Environ Med. 2018 Jun;60(6):e300-e306. doi: 10.1097/JOM.0000000000001309.

PMID:
29461386
8.

NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.

Roussy M, Bilodeau M, Jouan L, Tibout P, Laramée L, Lemyre E, Léveillé F, Tihy F, Cardin S, Sauvageau C, Couture F, Louis I, Choblet A, Patey N, Gendron P, Duval M, Teira P, Hébert J, Wilhelm BT, Choi JK, Gruber TA, Bittencourt H, Cellot S.

Genes Chromosomes Cancer. 2018 Jun;57(6):311-319. doi: 10.1002/gcc.22532. Epub 2018 Mar 28.

PMID:
29427526
9.

UBAP2L is amplified in a large subset of human lung adenocarcinoma and is critical for epithelial lung cell identity and tumor metastasis.

Aucagne R, Girard S, Mayotte N, Lehnertz B, Lopes-Paciencia S, Gendron P, Boucher G, Chagraoui J, Sauvageau G.

FASEB J. 2017 Nov;31(11):5012-5018. doi: 10.1096/fj.201601219RRR. Epub 2017 Jul 28.

PMID:
28754713
10.

Detection of an undersea acoustic communications network by an energy detector.

Shockley RC, Gendron PJ, Stevenson JM.

J Acoust Soc Am. 2017 Jun;141(6):4136. doi: 10.1121/1.4984102.

PMID:
28618829
11.

Evidence in support of Gaussian mixture models for sparse time varying ocean acoustic response functions.

Gendron PJ.

J Acoust Soc Am. 2017 Apr;141(4):EL413. doi: 10.1121/1.4981395.

PMID:
28464625
12.

Shallow water acoustic response and platform motion modeling via a hierarchical Gaussian mixture model.

Gendron PJ.

J Acoust Soc Am. 2016 Apr;139(4):1923. doi: 10.1121/1.4943552.

PMID:
27106339
13.

CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape.

Wang Z, Pan Q, Gendron P, Zhu W, Guo F, Cen S, Wainberg MA, Liang C.

Cell Rep. 2016 Apr 19;15(3):481-489. doi: 10.1016/j.celrep.2016.03.042. Epub 2016 Apr 7.

14.

Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors.

Lavallée VP, Krosl J, Lemieux S, Boucher G, Gendron P, Pabst C, Boivin I, Marinier A, Guidos CJ, Meloche S, Hébert J, Sauvageau G.

Blood. 2016 Jun 16;127(24):3054-61. doi: 10.1182/blood-2016-03-705053. Epub 2016 Mar 31.

15.

RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature.

Lavallée VP, Lemieux S, Boucher G, Gendron P, Boivin I, Armstrong RN, Sauvageau G, Hébert J.

Blood. 2016 May 19;127(20):2498-501. doi: 10.1182/blood-2016-03-703868. Epub 2016 Mar 11. No abstract available.

16.

Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations.

Lavallée VP, Lemieux S, Boucher G, Gendron P, Boivin I, Girard S, Hébert J, Sauvageau G.

Leukemia. 2016 Jul;30(7):1621-4. doi: 10.1038/leu.2016.19. Epub 2016 Feb 9. No abstract available.

PMID:
26859078
17.

GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.

Pabst C, Bergeron A, Lavallée VP, Yeh J, Gendron P, Norddahl GL, Krosl J, Boivin I, Deneault E, Simard J, Imren S, Boucher G, Eppert K, Herold T, Bohlander SK, Humphries K, Lemieux S, Hébert J, Sauvageau G, Barabé F.

Blood. 2016 Apr 21;127(16):2018-27. doi: 10.1182/blood-2015-11-683649. Epub 2016 Feb 1.

18.

Determinants of Return to Play After the Nonoperative Management of Hamstring Injuries in Athletes: A Systematic Review.

Fournier-Farley C, Lamontagne M, Gendron P, Gagnon DH.

Am J Sports Med. 2016 Aug;44(8):2166-72. doi: 10.1177/0363546515617472. Epub 2015 Dec 15. Review.

PMID:
26672025
19.

The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias.

Lavallée VP, Baccelli I, Krosl J, Wilhelm B, Barabé F, Gendron P, Boucher G, Lemieux S, Marinier A, Meloche S, Hébert J, Sauvageau G.

Nat Genet. 2015 Sep;47(9):1030-7. doi: 10.1038/ng.3371. Epub 2015 Aug 3.

PMID:
26237430
20.

Greater physical fitness is associated with better air ventilation efficiency in firefighters.

Gendron P, Freiberger E, Laurencelle L, Trudeau F, Lajoie C.

Appl Ergon. 2015 Mar;47:229-35. doi: 10.1016/j.apergo.2014.10.002. Epub 2014 Oct 24.

PMID:
25479992
21.

EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations.

Lavallée VP, Gendron P, Lemieux S, D'Angelo G, Hébert J, Sauvageau G.

Blood. 2015 Jan 1;125(1):140-3. doi: 10.1182/blood-2014-07-591529. Epub 2014 Oct 20.

22.

The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.

Zahreddine HA, Culjkovic-Kraljacic B, Assouline S, Gendron P, Romeo AA, Morris SJ, Cormack G, Jaquith JB, Cerchietti L, Cocolakis E, Amri A, Bergeron J, Leber B, Becker MW, Pei S, Jordan CT, Miller WH, Borden KL.

Nature. 2014 Jul 3;511(7507):90-3. doi: 10.1038/nature13283. Epub 2014 May 28.

23.

Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides.

Granados DP, Sriranganadane D, Daouda T, Zieger A, Laumont CM, Caron-Lizotte O, Boucher G, Hardy MP, Gendron P, Côté C, Lemieux S, Thibault P, Perreault C.

Nat Commun. 2014 Apr 9;5:3600. doi: 10.1038/ncomms4600.

24.

A functional screen reveals an extensive layer of transcriptional and splicing control underlying RAS/MAPK signaling in Drosophila.

Ashton-Beaucage D, Udell CM, Gendron P, Sahmi M, Lefrançois M, Baril C, Guenier AS, Duchaine J, Lamarre D, Lemieux S, Therrien M.

PLoS Biol. 2014 Mar 18;12(3):e1001809. doi: 10.1371/journal.pbio.1001809. eCollection 2014 Mar.

25.

Harnessing virtual machines to simplify next-generation DNA sequencing analysis.

Nocq J, Celton M, Gendron P, Lemieux S, Wilhelm BT.

Bioinformatics. 2013 Sep 1;29(17):2075-83. doi: 10.1093/bioinformatics/btt352. Epub 2013 Jun 20.

PMID:
23786767
26.

A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia.

Simon C, Chagraoui J, Krosl J, Gendron P, Wilhelm B, Lemieux S, Boucher G, Chagnon P, Drouin S, Lambert R, Rondeau C, Bilodeau A, Lavallée S, Sauvageau M, Hébert J, Sauvageau G.

Genes Dev. 2012 Apr 1;26(7):651-6. doi: 10.1101/gad.186411.111. Epub 2012 Mar 19.

27.

The exon junction complex controls the splicing of MAPK and other long intron-containing transcripts in Drosophila.

Ashton-Beaucage D, Udell CM, Lavoie H, Baril C, Lefrançois M, Chagnon P, Gendron P, Caron-Lizotte O, Bonneil E, Thibault P, Therrien M.

Cell. 2010 Oct 15;143(2):251-62. doi: 10.1016/j.cell.2010.09.014.

28.

Depletion of the cullin Cdc53p induces morphogenetic changes in Candida albicans.

Trunk K, Gendron P, Nantel A, Lemieux S, Roemer T, Raymond M.

Eukaryot Cell. 2009 May;8(5):756-67. doi: 10.1128/EC.00332-08. Epub 2009 Mar 6.

29.

Diffusion coefficients of several rhodamine derivatives as determined by pulsed field gradient-nuclear magnetic resonance and fluorescence correlation spectroscopy.

Gendron PO, Avaltroni F, Wilkinson KJ.

J Fluoresc. 2008 Nov;18(6):1093-101. doi: 10.1007/s10895-008-0357-7. Epub 2008 Apr 23.

PMID:
18431548
30.

[Prosecution of psychiatric patients: elements of reflections and practical applications.].

Bureau N, Roy R, Gendron P, Millaud F.

Sante Ment Que. 2001;26(1):202-15. French.

PMID:
18253600
31.

Efficacy of AR-R15896AR in the rat monofilament model of transient middle cerebral artery occlusion.

Bialobok P, Cregan EF, Sydserff SG, Eisman MS, Miller JA, Cross AJ, Simmons R, Gendron P, McCarthy DJ, Palmer GC.

J Stroke Cerebrovasc Dis. 1999 Nov-Dec;8(6):388-97.

PMID:
17895192
32.

Identification of a conserved RNA motif essential for She2p recognition and mRNA localization to the yeast bud.

Olivier C, Poirier G, Gendron P, Boisgontier A, Major F, Chartrand P.

Mol Cell Biol. 2005 Jun;25(11):4752-66.

33.

NMR structure of the active conformation of the Varkud satellite ribozyme cleavage site.

Hoffmann B, Mitchell GT, Gendron P, Major F, Andersen AA, Collins RA, Legault P.

Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7003-8. Epub 2003 Jun 2.

34.

RNAML: a standard syntax for exchanging RNA information.

Waugh A, Gendron P, Altman R, Brown JW, Case D, Gautheret D, Harvey SC, Leontis N, Westbrook J, Westhof E, Zuker M, Major F.

RNA. 2002 Jun;8(6):707-17.

35.

Leadzyme.

David L, Lambert D, Gendron P, Major F.

Methods Enzymol. 2001;341:518-40. No abstract available.

PMID:
11582802
36.

Quantitative analysis of nucleic acid three-dimensional structures.

Gendron P, Lemieux S, Major F.

J Mol Biol. 2001 May 18;308(5):919-36.

PMID:
11352582
37.

Pseudoknots in prion protein mRNAs confirmed by comparative sequence analysis and pattern searching.

Barrette I, Poisson G, Gendron P, Major F.

Nucleic Acids Res. 2001 Feb 1;29(3):753-8.

38.

Long-term functional end points following middle cerebral artery occlusion in the rat.

Hudzik TJ, Borrelli A, Bialobok P, Widzowski D, Sydserff S, Howell A, Gendron P, Corbett D, Miller J, Palmer GC.

Pharmacol Biochem Behav. 2000 Mar;65(3):553-62.

PMID:
10683498
39.

Low-affinity NMDA receptor antagonists. The neuroprotective potential of ARL 15896AR.

Palmer GC, Miller JA, Cregan EF, Gendron P, Peeling J.

Ann N Y Acad Sci. 1997 Oct 15;825:220-31. Review. No abstract available.

PMID:
9369989
40.

Excitation energies in statistical emission of light charged particles in heavy-ion reactions.

Beaulieu L, Samri M, Djerroud B, Auger G, Ball GC, Doré D, Galindo-Uribarri A, Gendron P, Hagberg E, Horn D, Jalbert E, Laforest R, Larochelle Y, Laville JL, Lopez O, Plagnol E, Pouliot J, Regimbart R, Roy R, Steckmeyer JC, St-Pierre C, Walker RB.

Phys Rev C Nucl Phys. 1995 Jun;51(6):3492-3495. No abstract available.

PMID:
9970457
41.

[An inventory for the evaluation of dangerousness in mental patients].

Millaud F, Roy R, Gendron P, Aubut J.

Can J Psychiatry. 1992 Nov;37(9):608-15. French.

PMID:
1477818
42.

[Mechanical ventilation in general surgery (200 cases)].

ALLEN M, GENDRON P, HAMELIN P.

Laval Med. 1962 Jan;33:17-22. French. No abstract available.

PMID:
13860558
43.

[Preliminary report on the application of cyclaine as a new surface anesthetic].

HUDON F, GENDRON P.

Laval Med. 1953 Feb;18(2):145-54. Undetermined Language. No abstract available.

PMID:
13053812

Supplemental Content

Loading ...
Support Center